Status:
COMPLETED
Utility Of Hemoglobin A1C For The Diagnosis Of Gestational Diabetes
Lead Sponsor:
Mike O'Callaghan Military Hospital
Conditions:
Gestational Diabetes Mellitus
Eligibility:
FEMALE
18+ years
Brief Summary
A prospective cohort research study is being conducted in the Mike O'Callaghan Federal Medical Center (MOFMC), Department of Family Medicine, Obstetrics Clinic to determine if early screening with hem...
Detailed Description
This is a prospective cohort research study conducted in the Mike O'Callaghan Federal Medical Center (MOFMC), Department of Family Medicine Residency and Obstetrics Clinics. Subjects will be pregnant ...
Eligibility Criteria
Inclusion
- THIS STUDY IS BEING CONDUCTED AT A MILITARY INSTALLATION. YOU MUST HAVE MILITARY INSURANCE IN ORDER TO PARTICIPATE IN THIS STUDY.
- Inclusion:
- Active duty or DoD beneficiaries of childbearing age 18 years or older with a positive pregnancy test (beta human chorionic gonadotropin).
- Exclusion:
- Active duty or DoD beneficiaries of childbearing age 18 years or older with a positive pregnancy test (beta human chorionic gonadotropin) known to have and/or develop during the study any of the following upon review of their medical record:
- Hemoglobinopathy (including sickle cell disease or trait, thalassemia)
- Chronic kidney disease
- Diabetes
- Active duty or DoD beneficiaries of childbearing age 18 years or older with a positive pregnancy test (beta human chorionic gonadotropin) taking any of the following:
- Erythropoietin
- Daily oral steroids
Exclusion
Key Trial Info
Start Date :
October 14 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
643 Patients enrolled
Trial Details
Trial ID
NCT02273193
Start Date
October 14 2014
End Date
July 1 2017
Last Update
November 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mike O'Callaghan Federal Medical Center
Nellis Air Force Base, Nevada, United States, 89191